Deubiquitinating enzymes regulate Hes1 stability and neuronal differentiation. by Kobayashi, Taeko et al.
Title Deubiquitinating enzymes regulate Hes1 stability and neuronaldifferentiation.
Author(s)
Kobayashi, Taeko; Iwamoto, Yumiko; Takashima, Kazuhiro;
Isomura, Akihiro; Kosodo, Yoichi; Kawakami, Koichi;
Nishioka, Tomoki; Kaibuchi, Kozo; Kageyama, Ryoichiro




© 2015 The Authors. FEBS Journal published by John Wiley
& Sons Ltd on behalf of FEBS.; This is an open access article
under the terms of the Creative Commons Attribution-
NonCommercial-NoDerivs License, which permits use and
distribution in any medium, provided the original work is
properly cited, the use is non-commercial and no modifications





Deubiquitinating enzymes regulate Hes1 stability and
neuronal differentiation
Taeko Kobayashi1,2,3,4, Yumiko Iwamoto1, Kazuhiro Takashima1, Akihiro Isomura1,2, Yoichi
Kosodo5, Koichi Kawakami6, Tomoki Nishioka7, Kozo Kaibuchi7 and Ryoichiro Kageyama1,2,3,4,8
1 Institute for Virus Research, Kyoto University, Japan
2 Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST), Kawaguchi, Japan
3 Graduate School of Medicine, Kyoto University, Japan
4 Graduate School of Biostudies, Kyoto University, Japan
5 Department of Anatomy, Kawasaki Medical School, Kurashiki, Japan
6 Division of Molecular and Developmental Biology, National Institute of Genetics, Shizuoka, Japan
7 Department of Cell Pharmacology, Graduate School of Medicine, Nagoya University, Japan
8 World Premier International Research Initiative/Institute for Integrated Cell and Material Sciences, Kyoto University, Japan
Keywords




T. Kobayashi, Institute for Virus Research,
Kyoto University, Shogoin-Kawahara,
Sakyo-ku, Kyoto 606-8507, Japan
Fax: +81 75 751 4807
Tel: +81 75 751 4013
E-mail: tkobayas@virus.kyoto-u.ac.jp
R. Kageyama, Institute for Virus Research,
Kyoto University, Shogoin-Kawahara,
Sakyo-ku, Kyoto 606-8507, Japan
Fax: +81 75 751 4807
Tel: +81 75 751 4011
E-mail: rkageyam@virus.kyoto-u.ac.jp
(Received 15 December 2014, revised 3
March 2015, accepted 30 March 2015)
doi:10.1111/febs.13290
Hairy and enhancer of split 1 (Hes1), a basic helix-loop-helix transcrip-
tional repressor protein, regulates the maintenance of neural stem/progeni-
tor cells by repressing proneural gene expression via Notch signaling.
Previous studies showed that Hes1 expression oscillates in both mouse
embryonic stem cells and neural stem cells, and that the oscillation contrib-
utes to their potency and differentiation fates. This oscillatory expression
depends on the stability of Hes1, which is rapidly degraded by the ubiqu-
itin/proteasome pathway. However, the detailed molecular mechanisms
governing Hes1 stability remain unknown. We analyzed Hes1-interacting
deubiquitinases purified from mouse embryonic stem cells using an Hes1-
specific antibody, and identified the ubiquitin-specific protease 27x
(Usp27x) as a new regulator of Hes1. We found that Hes1 was deubiquiti-
nated and stabilized by Usp27x and its homologs ubiquitin-specific prote-
ase 22 (Usp22) and ubiquitin-specific protease 51 (Usp51). Knockdown of
Usp22 shortened the half-life of Hes1, delayed its oscillation, and enhanced
neuronal differentiation in mouse developing brain, whereas mis-expression
of Usp27x reduced neuronal differentiation. These results suggest that these
deubiquitinases modulate Hes1 protein dynamics by removing ubiquitin
molecules, and thereby regulate neuronal differentiation of stem cells.
Introduction
Hairy and enhancer of split 1 (Hes1) is a member of
the basic helix-loop-helix family of transcriptional
repressor proteins, and is a downstream effecter of
canonical Notch signaling. Hes1 regulates many devel-
opmental events by repressing the expression of target
genes, including proneural genes that encode transcrip-
tional activators that promote neuronal differentiation
[1,2]. Hes1 expression oscillates with a period of 2–3 h
in cultured fibroblasts [3] and neural stem/progenitor
cells [4]. The expression dynamics of the Hes1 gene
Abbreviations
DUB, deubiquitinase; ES, embryonic stem; Hes1, hairy and enhancer of split 1; SVZ, sub-ventricular zone; TUJ-1, neuron-specific class III b-
tubulin; Usp/USP, ubiquitin-specific protease; VZ, ventricular zone.
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(Hes1) play crucial roles in proper developmental tim-
ings and fate determination steps in both embryonic
stem (ES) cells and neural stem cells [5–12]. Hes1 oscil-
lation dynamically changes the fate preference of ES
cells by controlling Notch signaling activity, and con-
tributes to heterogeneous responses of ES cells [5]. In
embryonic neural stem cells, Hes1 oscillation drives
the oscillatory expression of proneural factors. During
neural development, Hes1 expression disappears, while
proneural gene expression becomes sustained in differ-
entiating neurons but continues to oscillate in neural
stem cells [4]. Sustained Hes1 expression represses the
expression of genes involved in cell-cycle progression,
suggesting that Hes1 oscillation is important for the
proliferation of neural stem cells [4,9].
Hes1 oscillation is regulated by an auto-negative
feedback loop [3]. After activation of Hes1 transcrip-
tion via Notch signaling or serum stimulation, trans-
lated Hes1 represses the expression of its own gene by
directly binding to N-box sequences in its promoter.
The Hes1 gene products, both mRNA and protein, are
very unstable and degraded with a short half-life of
approximately 20 min, which enables Hes1 expression
to be restarted in a few hours. Previous reports dem-
onstrated that the instability of Hes1 gene products is
critical for its oscillation [3,13], but the detailed mecha-
nism of regulation of Hes1 stability remains to be
determined.
Ubiquitination and deubiquitination are well-regu-
lated processes that modulate protein stability and are
driven by specific ubiquitin ligases (E3 ligases) and de-
ubiquitinases (DUBs), respectively [14–18]. DUBs are
proteases that cleave ubiquitin moieties from ubiquiti-
nated substrates and regulate various cellular responses
by controlling substrate abundance and activity
[19,20]. Hes1 was shown to be rapidly degraded by the
ubiquitin/proteasome system [3], but neither the spe-
cific E3 ligases nor the DUBs have been identified.
Here, we identified DUBs regulating Hes1 stability by
affinity purification of Hes1 from ES cell lysates, fol-
lowed by LC/MS/MS, and analyzed the functional sig-
nificance of Hes1 protein stability with respect to its
oscillation and neuronal differentiation.
Results
Usp27x and its homologs deubiquitinate Hes1
We analyzed Hes1-interacting DUBs purified from
mouse ES cell lysates using Hes1-specific antibody,
and identified Usp19 and Usp27x, both of which are
ubiquitin-specific cysteine proteases (USPs) [17], by
LC/MS/MS. We examined their interactions with Hes1
in HEK293T cells. FLAG-tagged Usp19 and Usp27x,
together with hemagglutinin (HA)-tagged Hes1, were
expressed and immunoprecipitated using FLAG anti-
body. Both Usp19 and Usp27x interacted with Hes1
(Fig. 1A, lanes 8 and 9). To determine whether these
DUBs remove ubiquitin from Hes1, we co-transfected
His6-tagged Hes1 with both HA-tagged ubiquitin and
the corresponding Usp genes in C3H10T1/2 cells, and
then purified His6-tagged Hes1 after treatment with
the proteasome inhibitor MG132. Usp27x reduced the
amount of ubiquitinated Hes1 (Fig. 1C, lane 4), but
Usp19 and the catalytically inactive point mutants of
Usp27x, C87A (mt1) and H380A (mt2), did not
Fig. 1. Usp27x and its homologs interact with and deubiquitinate Hes1. (A) Interaction of USPs with Hes1. Each of the FLAG-tagged Usp
vectors was co-transfected with HA-tagged Hes1 into HEK293T cells. Cell lysates were immunoprecipitated using FLAG antibody. The
whole-cell extracts (input) and immunoprecipitates (IP) were blotted using FLAG antibody (FLAG) and HA antibody (Hes1). Asterisks indicate
degradation products of Usp proteins. (B) Interaction between endogenous Hes1 and Usp22. C3H10T1/2 cells were subjected to
immunoprecipitation with control rabbit IgG (IgG) or Hes1 antibody (Hes1). The whole-cell extracts (input) and immunoprecipitates (IP) were
blotted with Usp22 and Hes1 antibodies. (C) Usp27x and its homologs deubiquitinate Hes1. His6-tagged Hes1 and HA-tagged ubiquitin were
co-transfected with FLAG-tagged USPs into C3H10T1/2 cells. The transfection efficiencies were approximately 20% in all samples. Cells
were cultured in the presence of MG132 for 2 h, and lysed in denaturing buffer for purification. His-tagged Hes1 was purified with Ni-NTA
agarose beads and detected by western blotting using HA and Hes1 antibodies. (D) Lack of deubiquitination of the Hes1 homolog Hes7.
His6/FLAG-tagged Hes7 was co-transfected with both HA-tagged ubiquitin and each of the USPs into C3H10T1/2 cells, purified with Ni-NTA
beads, and blotted with FLAG and HA antibodies. (E) Deubiquitination of endogenous Hes1 by Usp27x. Plasmid encoding Usp27x or shRNA
was co-transfected with HA-tagged ubiquitin into C3H10T1/2 cells. Cells were cultured in the presence of 10 lM MG132 (proteasome
inhibitor) for 2 h and lysed. Hes1 was immunoprecipitated using Protein A beads cross-linked with Hes1 antibody, and analyzed by western
blotting. Rabbit IgG was used as a negative control. (F) Deubiquitination of endogenous Hes1 in Usp22 knockdown cells. C3H10T1/2 cells
were transfected with control or Usp22-specific siRNAs. Endogenous Hes1 was immunoprecipitated using Hes1 antibody and analyzed by
western blotting. The amount of polyubiquitinated Hes1 was quantified using an LAS3000mini luminescent image analyzer, in which the HA
signals were in the linear range, and normalized against that of precipitated Hes1 (bottom). nd, not detected. (G) Deubiquitination of
endogenous Hes1 by Usp22. Usp22 plasmid or control vector was co-transfected with HA-tagged ubiquitin into C3H10T1/2 cells, and
endogenous Hes1 was analyzed by immunoprecipitation. The molecular masses of Hes1, HA-tagged Hes1, His6-tagged Hes1 and His6/
FLAG-tagged Hes7 are 29.7, 30.8, 30.7 and 26.9 kDa, respectively.
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(Fig. 1C, lanes 3, 5 and 6). We also examined the
activities of the Usp27x homologs Usp22, Usp51 and
Usp3, which have homologous USP domains (Fig. 2C,
D). Immunoprecipitation analyses showed that all of
these homologs interacted with Hes1 (Fig. 1A, lanes
10–12). Furthermore, Usp22 and Usp51 reduced the
amount of ubiquitinated Hes1 (Fig. 1C, lanes 7 and
10). However, a high level of ubiquitinated Hes1
remained in Usp3-expressing cells (Fig. 1C, lane 11).
The catalytically inactive point mutants of Usp22,
C185A (mt1) and H479A (mt2), were also unable to
remove ubiquitin from Hes1 (Fig. 1C, lanes 8 and 9).
These results indicate that Usp27x, Usp22 and Usp51,
but not Usp19 or Usp3, act as Hes1 DUBs, and that
their catalytic activities are required to remove poly-
ubiquitin from Hes1.
We next examined whether Usp27x, Usp22 and
Usp51 have DUB activity specific to Hes1 or also act
on other Hes family proteins. FLAG-tagged Hes7 and
HA-tagged ubiquitin were co-expressed with or with-
out the various DUBs. Neither Usp27x nor its homo-
logs reduced the large amount of ubiquitinated Hes7,
a homolog of Hes1 (Fig. 1D, lanes 3–6), compared
with the control (lane 2). We further analyzed ubiquiti-
nation of endogenous Hes1 by immunoprecipitation
from C3H10T1/2 cells transfected with HA-tagged
ubiquitin. Over-expression of Usp27x reduced the level
of ubiquitinated endogenous Hes1 (Fig. 1E, lane 8).
However, knockdown of Usp27x by shRNA (79.5%
efficiency of knockdown as determined by quantitative
PCR) did little to alter the amount of ubiquitinated
Hes1 (lane 4), suggesting that Usp27x activity is com-
pensated for by its homologs. These results indicate
that Usp27x, Usp22 and Usp51 are able to specifically
deubiquitinate Hes1, and suggest that these Usp27x
homologs compensate for the functions of one
another.
We next sought to determine the region in Usp27x
that is required for the interaction with Hes1. Co-
immunoprecipitation of Hes1 with Usp27x deletion
mutants revealed that Usp27x interacts with Hes1 at
the conserved USP domain (Fig. 2A,B, lanes 13–16)
[17]. Because Usp22 and Usp51 also contain the USP
domain (Fig. 2D), these DUBs may recognize poly-
ubiquitinated Hes1 and interact with Hes1 via this
domain.
Usp27x and its homologs stabilize Hes1
To examine whether Usp27x and its homologs stabilize
Hes1 by deubiquitinating it, we monitored protein levels
of HA-tagged Hes1 in the presence of the translation
inhibitor cycloheximide. Over-expression of wild-type
Usp27x stabilized HA-tagged Hes1 (Fig. 3A, lanes 4–6),
but the inactive mutants of Usp27x did not increase the
half-life of HA-tagged Hes1 (lanes 7–9 and 10–12).
Usp22 stabilized HA-tagged Hes1, but the catalytica-
lly inactive mutants of Usp22 did not (Fig. 3B, lanes
1–3 and lanes 4–9). Usp51 stabilized HA-tagged Hes1,
but Usp3 did not (Fig. 3C, lanes 5–8 and lanes 9–12).
These results indicate that the catalytic activities of
Usp27x, Usp51 and Usp22 are important for stabilizing
Hes1 protein, and that Usp3 does not affect the stability
of Hes1. The catalytically inactive point mutants
Usp27x mt1 and Usp27x mt2 slightly decreased the
half-life of HA-tagged Hes1 compared with the control,
suggesting that these mutants may destabilize Hes1 by
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Fig. 2. Interactions of Usp27x and its deletion mutants with Hes1.
(A) Schematic representation of Usp27x and its mutants, showing
the region to which Hes1 binds. Usp27x has a catalytic USP
domain. Hes1 binds to the region between signatures 1 and 2
(asterisks) in the USP domain. n.d., not detected. (B) Co-
immunoprecipitation of Hes1 with Usp27x deletion mutants. HA-
tagged Hes1 was co-transfected with FLAG-tagged Usp27x and its
deletion mutants into HEK293T cells; their interactions were then
analyzed by immunoprecipitation with FLAG antibody and western
blotting using FLAG and HA antibodies. (C) Sequence alignment of
Usp27x homologs. Part of the phylogenetic tree generated by
ClustalW [39] from all deubiquitinases in mouse, with their identity
scores relative to Usp27x in parentheses (%). (D) Schematic
representation of the domains in Usp27x, Usp22 and Usp51. ZF,
zinc finger.
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Fig. 3. Usp27x and its homologs stabilize Hes1 protein. (A) Usp27x stabilizes Hes1. HA-tagged Hes1 was co-transfected with FLAG-tagged
Usp27x or its derivatives into C3H10T1/2 cells. Hes1 stability was analyzed by a cycloheximide (CHX) chase assays. Protein levels were
analyzed by western blotting with HA antibody (upper panels), and the relative amounts of Hes1 were quantified (lower panel). (B,C)
Usp27x homologs stabilize Hes1. HA-tagged Hes1 was co-transfected with FLAG-tagged Usp51, Usp3, Usp22 or Usp22 mutants into
C3H10T1/2 cells. Hes1 degradation was analyzed as in (A). (D–G) Usp27x, Usp22, Usp51 and Usp3 knockdown. C3H10T1/2 cells were
transfected with control, or siRNAs specific to Usp27x (D), Usp22 (E), Usp51 (F) or Usp3 (G). Protein levels were analyzed by western
blotting with Hes1 and actin antibodies, and quantified. The relative amounts of Hes1 were normalized against the amounts of actin. The
half-life of Hes1 protein was estimated from exponential curves fitted using Kaleidagraph software. (H) Estimated copy numbers of Usp22,
Usp27x and Usp51. The copy numbers of Usp22, Usp27x and Usp51 mRNA in 50 ng total RNA of C3H10T1/2 cells were determined by
quantitative PCR with known amounts of plasmids encoding these factors. Values are means  SEM from two independent experiments.
Asterisks indicate statistically significant differences (*P < 0.05, **P < 0.01; Student’s t test).
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We next examined the effects of DUB knockdown
on the protein stability of endogenous Hes1. We ana-
lyzed the knockdown of Usp27x, and its homologs
Usp22, Usp51 and Usp3. Knockdown of Usp22 using
two distinct siRNA sequences (KD1 and KD2) signifi-
cantly shortened the half-life of endogenous Hes1 from
24.4 min to 19.3 min (KD1) and 15.9 min (KD2)
(Fig. 3E). The shortened half-lives correlated with the
knockdown efficiency (79% in KD1 and 85% in
KD2). However, knockdown of Usp27x, Usp51 and
Usp3 using two siRNA sequences each did not have
any significant effect on the half-life of endogenous
Hes1, although the knockdowns were highly effective:
93.8% (KD1) and 89.8% (KD2) for Usp27x, 80.6%
(KD1) and 93.9% (KD2) for Usp51, and 97.3%
(KD1) and 94.2% (KD2) for Usp3 (Fig. 3D–G). We
found that C3H10T1/2 cells expressed abundant
Usp22 but little Usp27x or Usp51 (an approximately
100-fold difference between Usp22 and the others,
Fig. 3H). Endogenous Hes1 interacted with endoge-
nous Usp22 (Fig. 1B, lane 3), and Usp22 knockdown
increased the amount of polyubiquitinated endogenous
Hes1 (Fig. 1F, lanes 2 and 4). Over-expression of
Usp22 reduced the level of ubiquitinated endogenous
Hes1 (Fig. 1G, lanes 2 and 4). These results suggest
that Usp27x, Usp22 and Usp51 are able to stabilize
Hes1 protein, and that Usp22 is the main enzyme sta-
bilizing endogenous Hes1 in C3H10T1/2 fibroblast
cells.
Usp22 depletion modulates Hes1 protein
oscillation
To examine whether Usp22 modulates Hes1 oscillation
in C3H10T1/2 fibroblast cells, we analyzed temporal
changes in endogenous Hes1 mRNA and protein every
30 min after serum stimulation (Fig. 4A,B). Hes1
mRNA first peaked 1 h after serum treatment
(Fig. 4A), and Hes1 protein peaked at 1.25 h (Fig. 4B,
C, lane 3), which is 15 min after the peak of Hes1
mRNA, as described previously [3]. Knockdown of
Usp22 did not change the timings of the first peaks of
either mRNA or protein, indicating that the rates of
both transcription and translation of Hes1 are unaf-
fected in Usp22 knockdown cells. On the other hand,
the second peaks of both mRNA and protein were
affected in Usp22 knockdown cells. The second peak
of Hes1 mRNA occurred at 3 h in control cells and
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Fig. 4. Effect of Usp22 knockdown on Hes1 oscillation. (A,B). Hes1 oscillation was induced by serum stimulation in C3H10T1/2 cells. Levels
of Hes1 mRNA (A) and Hes1 and Usp22 proteins (B) were measured every 30 min after serum stimulation by quantitative PCR and western
blotting, respectively. Values are means  SEM of four (A) and three (B) independent experiments. Asterisks indicate statistically significant
differences (**P < 0.01, ***P < 0.001; Student’s t test and two-way ANOVA). (C) Representative blots of Usp22, Hes1 and actin. There are
two bands for Hes1 protein because of modification. The knockdown efficiency of Usp22 mRNA was 96.2%.
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3.5 h in Usp22 knockdown cells (Fig. 4A). The second
peak of Hes1 protein was observed at 3.25 h in control
cells, but Usp22 depletion weakened the oscillation
such that no clear second peak of protein was
observed (Fig. 4B,C, lane 7 and lanes 16–20). Usp22
was stably expressed after serum treatment (Fig. 4B,
C). Although Usp22 is reported to regulate gene tran-
scription by removing ubiquitin from histones H2B,
H2A and others [21–26], we found that level of Hes1
mRNA was unaffected by Usp22 knockdown before
serum stimulation (t = 0). After the first peak
(t = 1 h), the level of Hes1 mRNA was higher in
Usp22 knockdown cells than in control cells (Fig. 4A).
However, Hes1 protein levels were lower in Usp22
knockdown cells (Fig. 4B,C). These findings suggest
that Usp22 knockdown decreases the level of Hes1
protein and thereby weakens its own auto-inhibition,
which results in delay and up-regulation of the second
peak of Hes1 mRNA, and dampening of Hes1 oscilla-
tion at the population level.
We also examined Hes1 oscillation periods in indi-
vidual cells by real-time imaging, using a destabilized
luciferase reporter gene under the control of the Hes1
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Fig. 5. The period of Hes1 oscillation in individual fibroblast cells. (A) Schematic structures of reporter constructs used to establish the stable
cell line for real-time imaging. The reporters are flanked by the Tol2 transposon sequence (L200 and R175). Cells with these transgenes were
selected by fluorescence-activated cell sorting of mCherry-expressing cells. Continuous expression of the Notch intracellular domain (NICD)
is required to induce Hes1 expression in NIH3T3 cells. (B,C) Quantification of Hes1 expression dynamics in individual cells. Hes1 expression
was quantified by real-time imaging of the Hes1 promoter-driven luciferase reporter in individual control cells (B) and Usp22 knockdown cells
(C) for 24 h. Representative plots for three individual cells of each type are shown. a.u., arbitrary units. (D) Oscillation periods of Hes1. The
oscillation periodicity of the Hes1 promoter-driven luciferase reporter in individual cells was estimated by Fourier transform using the
maximum entropy method [5]. The results are displayed as box plots for oscillation periods of the bioluminescence in control cells (n = 74)
and Usp22 knockdown cells (n = 73). Asterisks indicate a statistically significant difference (***P < 0.001; Student’s t test). The mean
oscillation periods were 151.2 min in control cells and 175.8 min in Usp22 knockdown cells. Circles indicate outliers. (E) Estimated copy
numbers of Usp22, Usp27x and Usp51 in this cell line. Values are means  SEM for two independent experiments.
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reporter is able to monitor the timing of Hes1 tran-
scription [27]. As found for C3H10T1/2 cells, NIH3T3
cells expressed abundant Usp22 but little Usp27x and
Usp51 (Fig. 5E). We found that the oscillation periods
of individual cells were elongated by approximately
25 min, with greater variations in Usp22 knockdown
cells compared with those in control cells (Fig. 5B–D).
The knockdown efficiency of Usp22 was 81.8% in this
cell line. These results suggest that Hes1 was destabi-
lized by Usp22 knockdown, resulting in the delay of
Hes1 oscillation in Usp22 knockdown cells, and that
Usp22 contributes to control of the post-translational
delay in Hes1 oscillation by inhibiting its rapid degra-
dation. Elongated periods with greater variations
probably make the oscillation out of synchrony
between cells and thereby dampen Hes1 oscillation at
the population level (Fig. 4).
Usp22 and Usp27x regulate neuronal
differentiation of stem cells in the developing
mouse neocortex
Hes1 is highly expressed in neural stem cells, and its
oscillation plays a crucial role in neuronal differentia-
tion of the developing brain [1,4,9]. Neural stem cells
and intermediate progenitors exist in the ventricular
zone (VZ) and the sub-ventricular zone (SVZ), respec-
tively, while differentiated neurons migrate out into
the cortical plate via the intermediate zone during neu-
ral development. Previous studies showed that mis-
expression of Hes1 in neural stem cells inhibits neuro-
nal differentiation, and the transfected cells are
retained in the VZ [28]. We examined the function of
Hes1 DUBs in vivo following in utero electroporation
of knockdown or mis-expression vectors. This was per-
formed by co-electroporation with nuclear-localizing
GFP into neural stem cells of the VZ in embryonic
day (E)13.5 mouse brain. The electroporated cells were
examined at E15.5. In control samples, the majority of
GFP-positive cells were present in the VZ or the SVZ.
Approximately 20% of GFP-positive cells had
migrated and were present in the intermediate zone
and the cortical plate, which were positive for the neu-
ronal marker neuron-specific class III b-tubulin (TUJ-
1) (Fig. 6A–E). Usp22 knockdown led to a significant
increase in the number of electroporated cells in the
intermediate zone and the cortical plate (42.2%, repre-
senting a 24.1% absolute increase compared with the
control), but a significant decrease in the progenitor
cell population in the VZ and SVZ (Fig. 6A,B,E).
However, mis-expression of Usp22 did not have signifi-
cant effects on neuronal differentiation (data not
shown), probably because Usp22 was abundantly
expressed in the developing brain (Fig. 6F). On the
other hand, mis-expression of Usp27x, which was not
expressed in the developing brain (Fig. 6F), signifi-
cantly reduced the number of electroporated cells in
the intermediate zone and the cortical plate (1.7%, rep-
resenting a 17.9% decrease compared with the control),
and most GFP-positive cells remained in the VZ and
SVZ as undifferentiated cells (negative for TUJ-1)
(Fig. 6C–E). These data suggest that both Usp22 and
Usp27x negatively regulate neuronal differentiation
in vivo.
Discussion
In this study, we identified new regulators of Hes1 sta-
bility and function. We found that Hes1 was deubiqui-
tinated and stabilized by the DUBs Usp27x, Usp22
and Usp51. These DUBs physically interact with Hes1
and remove ubiquitin molecules from Hes1 by their
catalytic activities. Over-expression of these DUBs sta-
bilizes Hes1 and increases its half-life. Knockdown of
Usp22 significantly shortens the half-life of endogenous
Hes1, suggesting that Usp22 is the main DUB for
Hes1. Moreover, Usp22 knockdown affects Hes1 oscil-
lation and enhances neuronal differentiation in the
mouse developing brain, while Usp27x mis-expression
maintains the progenitor state. These results suggest
that deubiquitination regulates Hes1 functions by sta-
bilizing it in vivo.
We first identified Usp27x as an interacting partner
of Hes1 in ES cells. However, Usp27x knockdown did
not significantly alter either the half-life or the poly-
ubiquitination level of endogenous Hes1 in fibroblasts
(Figs 1E and 3D), and we did not detect any signifi-
cant phenotypes in Usp27x knockout mouse embryos
(data not shown). Usp22 is required for embryonic
development and is strongly expressed in the mouse
embryonic brain (Fig. 6F) [23,29]. We observed that
the levels of both Usp27x and Usp51 were much lower
than that of Usp22 in fibroblast cells and the mouse
developing brain. These results suggest that Usp22
may compensate for the loss of its homologs.
Hes1 is reported to be important for maintenance of
the undifferentiated state of both tumor cells and qui-
escent cells [30,31]. Usp22 has been identified as a
member of an 11-gene cancer stem cell signature, and
may stabilize Hes1 levels in cancer stem cells and inhi-
bit their differentiation in malignant tumors [32,33].
Recently, Usp22 was reported to be the transcriptional
repressor of the SRY (sex-determining region Y)-box 2
gene (Sox2) in ES cells, whereby Usp22 is required for
efficient differentiation into all three germ layers [25].
Sox2 is also expressed in neural stem cells and is
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required for maintenance of neural stem/progenitor
cells and their neuronal differentiation [34]. It is possi-
ble that Usp22 also regulates expression of other genes
required for neural stem cell maintenance at the tran-
scriptional and post-translational levels, and maintains
the stem cell pool. Further studies are required to clar-
ify the mechanisms of the detailed regulation by
Usp22 for neuronal differentiation in the developing
brain.
Our results demonstrate that Usp22 regulates the
oscillation period of Hes1. Usp22 knockdown elon-
gates the period of Hes1 oscillation in fibroblast cells.
The first peaks of Hes1 mRNA and protein occur at
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Fig. 6. Usp27x and Usp22 repress neuronal differentiation in the developing brain. (A,B) Usp22 knockdown in neural stem cells. Control
siRNA or Usp22 siRNA were electroporated with the nuclear-localizing GFP vector into the neocortex of E13.5 mouse embryos in the same
mother uterus, and harvested at E15.5. Sections were stained with GFP antibody (green), TUJ-1 antibody (red) and 40,6-diamidino-2-
phenylindole (DAPI) (blue). (C,D) Mis-expression of Usp27x in neural stem cells. Control vector or Usp27x expression vector were
electroporated as described in (A). Boxed regions in (A) and (C) are enlarged in (B) and (D), respectively. White lines in (B) and (D) indicate the
surface of the ventricle. Scale bars = 100 lm. (E) Quantification of cell distribution, showing the percentage of GFP-positive cells in various
cortical layers (CP, cortical plate; IZ, intermediate zone; MZ, marginal zone; SVZ, sub-ventricular zone; VZ, ventricular zone). Values are means
 SEM from four independent experiments. Asterisks indicate statistically significant differences (***P < 0.001, **P < 0.01; Student’s t test).
Two embryos and at least two sections from each embryo were analyzed for each independent experiment. (F) Expression of Hes1, Usp22
and Usp27x in the developing brain. In situ hybridization of Hes1, Usp22 and Usp27x in sagittal brain sections of E13.5 mouse embryo.
Sections were hybridized with dioxygenin-labeled antisense RNA probes, and stained using the nitro blue tetrazolium 5-bromo-4-chloro-3-
indolyl-phosphate detection system as described previously [28]. Sequence information for the RNA probes is available upon request.
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knockdown cells after serum stimulation, indicating
that the rates of Hes1 transcription and translation are
not affected by Usp22 depletion. However, the second
peak of Hes1 mRNA was delayed, and Hes1 protein
gradually decreased, resulting in damped oscillation
(Fig. 4A,B). Single cell imaging revealed that the oscil-
lation periods of individual cells were elongated with
greater variations by Usp22 knockdown compared
with those of control (Fig. 5C,D). These results sug-
gest that Usp22 depletion destabilizes Hes1 protein
and leads to more rapid degradation, which elongates
the delay of auto-repression and slows or dampens
oscillation. Thus, deubiquitination of Hes1 modulates
auto-regulation of its own gene expression and thereby
regulates the dynamics of oscillatory expression.
In the developing central nervous system, stable
Hes1 oscillation is required to maintain neural stem
cells; Hes1 oscillation represses the proneural genes
required to promote neuronal differentiation, expres-
sion of some of which has been reported to oscillate in
neural stem cells [4,9]. During neuronal differentiation,
Hes1 oscillation is damped, which causes up-regulation
of proneural genes and directs the neural stem cells
toward neuronal differentiation. Usp22 depletion elon-
gates the Hes1 oscillation period or dampens its oscil-
lation, which may give neural stem cells more
opportunity to express proneural genes continuously,
resulting in a significant increase in differentiating
cells. On the other hand, Usp27x mis-expression inhib-
ited neuronal differentiation of progenitor cells, sug-
gesting that deubiquitination of Hes1 allows Hes1 to
suppress proneural genes continuously. To our knowl-
edge, this is the first report demonstrating that post-
translational modification of Hes1 modulates its oscil-
lation and function in vitro and in vivo.
Experimental procedures
Cell culture and transfection
C3H10T1/2 mouse fibroblast cells, NIH3T3 cells and
HEK293T cells were grown in Dulbecco’s modified Eagle’s
medium with 10% fetal bovine serum. To examine Hes1
oscillation, C3H10T1/2 cells cultured in Dulbecco’s modified
Eagle’s medium with 5% fetal bovine serum were stimulated
with the same medium (5% fetal bovine serum) at t = 0 as
described previously [35]. For half-life measurement, 20 lg/
mL cycloheximide (Sigma, St. Louis, MO, USA) was added
to the culture medium at t = 0. Plasmids and siRNA were
transfected with polyethyleneimine (Polysciences, Inc., War-
rington, PA, USA) and Lipofectamine RNAiMAX (Invitro-
gen, Life Technologies, Carlsbad, CA, USA), respectively,
according to the manufacturers’ instructions. siRNA
duplexes of negative control, Silencer Select Validated
siRNA and MISSION predesigned were purchased from
Ambion (Life Technologies) or Sigma.
Plasmids
We cloned DUBs from cDNA of mouse MG1.19 ES cells
into the expression vector under the control of the human
elongation factor promoter. HA-tagged Hes1, His6-tagged
Hes1, His6/FLAG-tagged Hes7 and HA-tagged ubiquitin
were cloned into the pCI vector (Promega, Madison, WI,
USA). Expression of Usp27x shRNA was driven by the
h7SK promoter in the puromycin resistance plasmid [35].
The knockdown sequence for Usp27x shRNA was 50-
GGCGCAAGATCACTACGTACATT-30.
Measurement of Hes1 protein and mRNA
For protein analysis, each sample was lysed in lysis buffer
(0.5% Nonidet P-40 (Nacalai Tesque, Kyoto, Japan),
100 mM NaCl, 5 mM MgCl2, 10 mM imidazole, 50 mM
Tris/HCl, pH 8.0) at the time points indicated in figures,
and 10–20 lg total protein at each time point was analyzed
by western blotting with Hes1 antibody (1:2000; a kind gift
from Tetsuo Sudo, TORAY Industries Inc., Tokyo, Japan),
Usp22 antibody (1:2000; Novus Biologicals, Littleton, CO,
USA) and actin antibody (1:2000; Sigma); actin was used
as a loading control. The bands of Hes1, actin and Usp22
were quantified using a LAS3000mini luminescent image
analyzer (GE Healthcare UK Ltd, Buckinghamshire, UK),
and the intensities of Hes1 and Usp22 were divided by that
of actin to calculate relative levels. For mRNA analysis,
total RNA was extracted using RNeasy Plus mini kits (Qia-
gen GmbH, Hilden, Germany), and analyzed by real-time
PCR (Applied Biosystems, Life Technologies) as described
previously [35]. Primer sequences are available upon
request.
Immunoprecipitation
For identification of DUBs, proteins associated with endog-
enous Hes1 in mouse ES cells (MG1.19) were immunopre-
cipitated using rabbit Hes1 antibody described previously
[5] and identified by LC/MS/MS as described previously
[36]. The antibody or control IgG was cross-linked to Pro-
tein A beads (GE Healthcare) by treatment with dithiobis
(succinimidyl propionate), and Hes1 knockdown cells were
used as negative controls [5]. After washing the beads, five
times with binding buffer (1% Nonidet P-40, 150 mM
NaCl, 1 mM EDTA, 20 mM Tris/HCl, pH 8.0) and then
three times with washing buffer (150 mM NaCl, 1 mM
EDTA, 20 mM Tris/HCl, pH8.0) at 4 immunoprecipitated
proteins were eluted with guanidine hydrochloride buffer
(7 M guanidine hydrochloride, 10 mM dithiothreitol,
50 mM Tris/HCl, pH 8.0) and analyzed by LC/MS/MS
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[36]. To detect the interaction of DUBs with Hes1,
HEK293T cells were transfected with plasmids encoding
FLAG-tagged DUBs and HA-tagged Hes1, and lysed in
binding buffer containing both protease inhibitors
[Complete Protease Inhibitor Cocktail, Roche, (Basel, Swit-
zerland) and 1mM phenylmethylsulfonyl fluoride, Nacalai
Tesque] and phosphatase inhibitors (10mM beta-Glycero-
phosphate, 1mM Sodium Orthovanadate, 1mM Sodium
Fluoride, 1mM Sodium Pyrophosphate, Nacalai Tesque).
Proteins immunoprecipitated with FLAG M2 agarose
(Sigma) were washed three times with binding buffer and
twice with washing buffer, and then eluted using 3 9
FLAG peptide (Sigma) and analyzed by western blotting
using horseradish peroxidase-conjugated FLAG M2 anti-
body (1:5000; Sigma) and HA antibody (3F10, 1:2000;
Roche). To detect interaction between endogenous Hes1
and Usp22, the nuclear fraction was extracted from
C3H10T1/2 cells and subjected to immunoprecipitation
with Hes1 antibody [5] using a Nuclear Complex Co-IP kit
(Active Motif, Carlsbad, CA, USA) according to the manu-
facturer’s instructions, and analyzed by western blotting
using Hes1 and mouse monoclonal Usp22 antibodies
(1:1000, Santa Cruz Biotechnology Inc., Dallas, TX, USA).
All signals obtained in western blotting experiments are in
the linear range of the LAS3000mini quantification.
Ubiquitination assay
Plasmids encoding DUB, His6-tagged Hes1 or His6/FLAG-
tagged Hes7 and HA-tagged ubiquitin were co-transfected
into C3H10T1/2 cells, which were lysed in guanidine hydro-
chloride lysis buffer (0.5% NP-40, 100 mM NaCl, 5 mM
MgCl2, 10 mM imidazole, 6 M guanidine hydrochloride,
50 mM Tris/HCl, pH 8.0) and sonicated in an ice-cold
water bath to decrease viscosity. His6-tagged Hes1 or Hes7
were purified using Ni-NTA agarose beads (Qiagen),
washed three times with guanidine hydrochloride lysis buf-
fer and twice with lysis buffer, and then eluted using SDS
sample buffer. To detect ubiquitinated endogenous Hes1,
proteins were immunoprecipitated using rabbit Hes1 anti-
body-conjugated Protein A beads or control rabbit IgG-
conjugated Protein A beads from C3H10T1/2 cells that
were co-transfected with both HA-tagged ubiquitin and the
corresponding USPs, or both HA-tagged ubiquitin and
shRNA or siRNA. For shRNA knockdown and Usp over-
expression, transfected cells were selected using 2 lg/mL
puromycin. Cells were lysed in binding buffer containing
2 mM N-Ethylmaleimide after MG132 treatment for 2 h.
Precipitated proteins were washed five times with binding
buffer and twice with washing buffer, and eluted using
SDS sample buffer. Purified samples were analyzed by wes-
tern blotting using the following antibodies: rabbit Hes1
antibody, horseradish peroxidase-conjugated HA antibody
and FLAG M2 antibody at the same dilutions as described
above.
Real-time imaging
We used NIH3T3 cells carrying two reporters, ubiquitin–
nuclear localization signal (NLS)–luc2 under the control of
the Hes1 promoter to monitor Hes1 transcription, and
mCherry–NLS under the control of the human elongation
factor promoter to track single cells. The Notch intracellular
domain (NICD) was expressed under the control of the tetra-
cycline-responsive promoter (Tet-On, Takara Bio Inc.,
Shiga, Japan) to induce Hes1 expression. These transgenes
were incorporated into NIH3T3 cells using the Tol2 transpo-
son system [37]. Cells were cultured in Dulbecco’s modified
Eagle’s medium, 10% fetal bovine serum, 1 mM luciferin,
1 lg/mL doxycycline. Bioluminescence was measured for
20–24 h as described previously [9]. Oscillation periodicity
was estimated by the maximum entropy method of spectrum
analysis using ImageJ software (http://rsb.info.nih.gov/ij/
index.html) [5]. Samples with very low signals, short periods
of less than 30 min, or long periods of more than 400 min
were excluded as experimental noise and outliers. This cell
line exhibited robust Hes1 oscillation in individual cells
because of exogenous Notch intracellular domain expression.
Our previous report demonstrated that the oscillation period
of Hes1 in C3H10T1/2 cells was more variable among cells
and oscillation cycles without serum stimulation, because
cell–cell interaction probably induces unpredictable activa-
tion of Notch signaling, resulting in unstable and fragile
Hes1 oscillation in individual cells [27]. The NIH3T3 cell line
was much better than C3H10T1/2 cells for the purpose of
accurately evaluating the change in oscillation periods by
Usp22 knockdown in individual cells.
In utero electroporation, immunohistochemistry
and quantification
In utero electroporation was performed as described previ-
ously [4]. siRNA (50 lM) or 2 lg/lL plasmid encoding
Usp27x with 0.5 lg/lL reporter plasmid encoding Histone
H2B (H2B)–green fluorescent protein (GFP) under the con-
trol of the CAG promoter (chicken beta-actin promoter
with CMV enhancer) was electroporated into neural stem
cells after it was injected into the lateral ventricle of E13.5
mouse embryos. Approximately five embryos were electro-
porated for each sample, and all embryos were sectioned.
Embryos at E15.5 were fixed in 4% paraformaldehyde,
cryoprotected, embedded in Tissue-Tek O.C.T.TM Com-
pound (Sakura Finetek Japan Co., Ltd., Tokyo, Japan),
and cryosectioned at 16 lm. Fixed cryosections were
blocked using 5% normal goat serum and incubated with
the primary antibodies chicken GFP (1:500; Abcam, Cam-
bridge, UK), rabbit TUJ-1 (1:500; Covance Research Pro-
ducts Inc., Denver, PA, USA) and rat T-box brain protein
2 (Tbr2) (1:500; eBioscience, San Diego, CA, USA), and
then incubated with secondary antibodies conjugated with
Alexa488 or Alexa594 (1:500; Invitrogen) and 40,6-diamidi-
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no-2-phenylindole. GFP-positive cells were counted within
an area 200 lm wide perpendicular to the apical/basal axis
of the cortical layers in at least four sections in two
embryos. Tbr2 is a marker of intermediate progenitor cells,
and is expressed in the SVZ [38]. We considered that the
Tbr2-positive region represents the SVZ, and distinguished
two regions of the cortical layers: the apical region (the
inner 41.4% region of the brain wall), which includes the
VZ and the SVZ, and the basal region, which includes the
cortical plate and the intermediate zone.
Statistical analyses
Statistical analyses and curve fitting were performed using
Kaleidagraph software (Synergy Software, Reading, PA,
USA). Statistical differences were examined using Student’s
t test and two-way ANOVA, and P values < 0.05 was con-
sidered significant.
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